Trials / Completed
CompletedNCT02350634
18F-AV-1451 High Resolution Autopsy Study
A High Resolution Autopsy Study Evaluating the Relationship of 18F-AV-1451 PET Imaging and Tau Pathology
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- 60 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to examine the relationship between imaging results detected on a 18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flortaucipir F18 | Subjects will receive a single IV bolus injection of 370 megabecquerel (MBq) (10 millicurie \[mCi\]) of flortaucipir. |
Timeline
- Start date
- 2016-11-26
- Primary completion
- 2017-06-16
- Completion
- 2017-06-16
- First posted
- 2015-01-30
- Last updated
- 2025-06-10
- Results posted
- 2025-06-10
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02350634. Inclusion in this directory is not an endorsement.